original ) (raw )HDAC inhibitor Scriptaid induces glioma cell apoptosis through JNK activation and inhibits telomerase activity
Ellora Sen
Journal of Cellular and Molecular Medicine, 2009
View PDFchevron_right
Development of a histone deacetylase 6 inhibitor and its biological effects
Paul Marks
Proceedings of the National Academy of Sciences, 2013
View PDFchevron_right
Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor
OMAR AZIZ
Bioorganic & Medicinal Chemistry Letters, 2018
View PDFchevron_right
Discovery of (2E)-3-{2-Butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an Orally Active Histone Deacetylase Inhibitor with a Superior Preclinical Profile
Pauline Yeo
Journal of Medicinal Chemistry, 2011
View PDFchevron_right
Histone deacetylase inhibitors
Claude Monneret
European Journal of Medicinal Chemistry, 2005
View PDFchevron_right
Binding Mode Analysis of 3-(4Benzoyl1-methyl-1 H -2-pyrrolyl)- N -hydroxy-2-propenamide: A New Synthetic Histone Deacetylase Inhibitor Inducing Histone Hyperacetylation, Growth Inhibition, and Terminal Cell Differentiation
Roberto Scatena , Gianluca SBARDELLA
Journal of Medicinal Chemistry, 2002
View PDFchevron_right
Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability
Christine Tam
Journal of Biological Chemistry, 2013
View PDFchevron_right
SAR and biological evaluation of analogues of a small molecule histone deacetylase inhibitor N-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide (MGCD0103)
Nancy Zhou
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
Histone Deacetylase Inhibitor as a Novel Anticancer Agent: A Review
pranit saraswat
2015
View PDFchevron_right
Histone deacetylase inhibitors: Opening a new field of research in the development of alternative methods
Joanna Fraczek
View PDFchevron_right
Apoptotic effects of the novel histone deacetylase inhibi tor BML210 on HeLa cells
Karl-eric Magnusson
2008
View PDFchevron_right
Antitumor activity of N-hydroxy-7-(2-naphthylthio) heptanomide, a novel histone deacetylase inhibitor
JIyong Lee
Biochemical and Biophysical Research Communications, 2007
View PDFchevron_right
Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma
Soledad Fernandez
Hepatology, 2007
View PDFchevron_right
Discovery of a potent histone deacetylase (HDAC) 3/6 selective dual inhibitor
pondy murugappan ramanujulu
European Journal of Medicinal Chemistry, 2019
View PDFchevron_right
Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents
Loredana Cappellacci
Current Medicinal Chemistry, 2020
View PDFchevron_right
Antimalarial Activity of Phenylthiazolyl-Bearing Hydroxamate-Based Histone Deacetylase Inhibitors
Victor Melendez
Antimicrobial Agents and Chemotherapy, 2008
View PDFchevron_right
CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo
Christine Orr
Molecular cancer …, 2006
View PDFchevron_right
Identification of HDAC6‐Selective Inhibitors of Low Cancer Cell Cytotoxicity
Oleksii Dubrovskyi
ChemMedChem, 2015
View PDFchevron_right
Rational Development of Histone Deacetylase Inhibitors as Anticancer Agents: A Review
Jurgen Venitz
Molecular Pharmacology, 2005
View PDFchevron_right
N -Acylhydrazone derivatives as potent histone deacetylase 6 inhibitors
Lorrane Chaves
Proceedings of 4th International Electronic Conference on Medicinal Chemistry, 2018
View PDFchevron_right
Molecular modelling studies of Histone Deacetylase inhibitors as anticancer agents
Sibi Narayanan
Journal of Pharmacy Research, 2013
View PDFchevron_right
Mechanisms of Selective Anticancer Action of Histone Deacetylase Inhibitors
Saverio Minucci
Cell Cycle, 2005
View PDFchevron_right
Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects
M. Lauricella
International Journal of Oncology, 2008
View PDFchevron_right
Histone deacetylase inhibitors as a potential therapeutic agent for human cancer treatment
Evangelos Misiakos
Targeted Oncology, 2006
View PDFchevron_right
Potential anti-cancer activity of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a histone deacetylase inhibitor, against breast cancer both in vitro and in vivo
Jin-Suck Suh
Cancer Science, 2011
View PDFchevron_right